BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15273114)

  • 1. Possible mechanism of miltefosine-mediated death of Leishmania donovani.
    Verma NK; Dey CS
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3010-5. PubMed ID: 15273114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
    J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes.
    Marinho Fde A; Gonçalves KC; Oliveira SS; Oliveira AC; Bellio M; d'Avila-Levy CM; Santos AL; Branquinha MH
    Mem Inst Oswaldo Cruz; 2011 Jun; 106(4):507-9. PubMed ID: 21739043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
    Verma NK; Singh G; Dey CS
    Exp Parasitol; 2007 May; 116(1):1-13. PubMed ID: 17161839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes.
    Paris C; Loiseau PM; Bories C; Bréard J
    Antimicrob Agents Chemother; 2004 Mar; 48(3):852-9. PubMed ID: 14982775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death.
    Mishra J; Singh S
    Exp Parasitol; 2013 Oct; 135(2):397-406. PubMed ID: 23968687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovani.
    Azzouz S; Maache M; Dos Santos MF; Sarciron ME; Petavy AF; Osuna A
    J Parasitol; 2006 Oct; 92(5):877-83. PubMed ID: 17152926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
    Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.
    Azzouz S; Maache M; Garcia RG; Osuna A
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):60-5. PubMed ID: 15667597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.
    Tiwari B; Pahuja R; Kumar P; Rath SK; Gupta KC; Goyal N
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.
    Wadhone P; Maiti M; Agarwal R; Kamat V; Martin S; Saha B
    J Immunol; 2009 Jun; 182(11):7146-54. PubMed ID: 19454711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
    Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
    Escobar P; Yardley V; Croft SL
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).
    Seifert K; Matu S; Javier Pérez-Victoria F; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2003 Oct; 22(4):380-7. PubMed ID: 14522101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Agents against Miltefosine-Unresponsive Leishmania donovani.
    Das M; Saha G; Saikia AK; Dubey VK
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7826-9. PubMed ID: 26392497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.
    Ganguly S; Bandyopadhyay S; Sarkar A; Chatterjee M
    J Microbiol Methods; 2006 Jul; 66(1):79-86. PubMed ID: 16316700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B.
    Shadab M; Jha B; Asad M; Deepthi M; Kamran M; Ali N
    PLoS One; 2017; 12(2):e0171306. PubMed ID: 28170432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
    Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S
    Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
    Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.